Cargando…
A Case Series of Immune Flare and Lupus Anticoagulant Following COVID-19 Vaccination
Autores principales: | Cherabuddi, Medha Reddy, Al-Saheli, Zaid, Donthireddy, Vijaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665187/ http://dx.doi.org/10.1182/blood-2022-159789 |
Ejemplares similares
-
Role of Anticoagulation and IVIG in Treatment of Vaccine-Induced Thrombotic Thrombocytopenia (VITT)
por: Tariq, Anosha, et al.
Publicado: (2022) -
Assessing Immune Response to 3(rd) Dose of COVID-19 Vaccine Series in Patients Undergoing Cancer Treatment at University Medical Center- New Orleans
por: Nguyen, Anh Q., et al.
Publicado: (2022) -
COVID-19 Vaccination Associated Severe Immune Thrombocytopenic Purpura
por: Sharawi, Said, et al.
Publicado: (2022) -
Real World Outcomes of Therapeutic Anticoagulation Use in Moderate COVID-19 Infection in Hospitalised Patients
por: Creeper, Katherine J., et al.
Publicado: (2022) -
Immune Thrombocytopenia Purpura Relapse in Patients Who Received mRNA COVID-19 Vaccines
por: Qasim, Hana, et al.
Publicado: (2022)